Gm129 Activators
Gm129 Activators are a collection of chemical compounds that serve to elevate the functional activity of Gm129 through specific and indirect mechanisms within signaling pathways. Forskolin, by raising cAMP levels, activates the PKA signaling pathway, which is known to indirectly boost the activity of Gm129 by phosphorylating proteins that interact with Gm129's functional pathways. Similarly, the inhibition of phosphodiesterase by 3-Isobutyl-1-methylxanthine maintains elevated cAMP levels, resulting in enhanced PKA signaling and subsequent phosphorylation of proteins that augment Gm129 activity. PMA, through the activation of PKC, modifies transcription factors or proteins that interact with Gm129's pathways, indirectly stimulating Gm129 function. Ionomycin and A23187 both act by increasing intracellular calcium levels, triggering calcium-dependent kinases and phosphatases that promote the pathways involving Gm129, thereby increasing its activity.
Continuing with the theme of cyclic nucleotide modulation, Rolipram and BAY 60-7550 selectively inhibit PDE4 and PDE2A, respectively, causing a surge in cAMP and cGMP levels which leads to amplified PKA activity and enhanced Gm129 function. Sildenafil and Vardenafil, by inhibiting PDE5, prevent cGMP breakdown, and this elevation of cGMP can indirectly potentiate Gm129's activity through cGMP-dependent protein kinases. Zaprinast's inhibition of PDE9A similarly increases cGMP levels, indirectly intensifying Gm129's functional activity. Anagrelide's targeting of PDE3A raises cAMP, which activates PKA and leads to phosphorylation of proteins in Gm129's pathways, enhancing Gm129 activity. Lastly, Terbutaline activates adenylate cyclase through the β2-adrenergic receptor, increasing cAMP and subsequently PKA activity, resulting in the phosphorylation of proteins that indirectly stimulate Gm129's functional pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, leading to increased production of cyclic AMP (cAMP), a second messenger known to enhance Gm129 activity by facilitating the cAMP-dependent protein kinase A (PKA) signaling pathway. Increased PKA activity can then phosphorylate target proteins that directly or indirectly activate Gm129 by enhancing its associated cellular processes. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
This compound is a non-selective inhibitor of phosphodiesterases, enzymes that break down cAMP and cGMP. By preventing the degradation of cAMP, 3-Isobutyl-1-methylxanthine indirectly increases PKA activity, which then promotes the phosphorylation of proteins that are part of the signaling cascade that enhances Gm129 function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC), which influences numerous signaling pathways. The activation of PKC can lead to the modulation of transcription factors or other proteins that interact with the pathways where Gm129 is a critical component, thus enhancing the functional activity of Gm129. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent kinases and phosphatases, affecting signaling pathways that Gm129 is involved in. The elevation of calcium can enhance the pathway activities that Gm129 is part of, therefore indirectly enhancing the functional activity of Gm129. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), leading to increased intracellular levels of cAMP. This accumulation of cAMP can result in augmented activation of PKA and subsequent phosphorylation of proteins within Gm129's signaling pathways, thereby enhancing Gm129 activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that increases intracellular calcium concentrations, leading to the activation of calcium-sensitive signaling molecules and pathways that can enhance Gm129 activity by modulating proteins and enzymes that are involved in Gm129's functional pathways. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterases 9A (PDE9A), which increases cGMP levels in cells. The accumulation of cGMP can then potentiate the signaling pathways that involve Gm129, leading to the enhancement of its functional activity through the modulation of cGMP-dependent protein kinases and other molecules within these pathways. | ||||||
Anagrelide hydrochloride | 58579-51-4 | sc-203513 sc-203513A | 10 mg 50 mg | $103.00 $587.00 | 1 | |
Anagrelide is a phosphodiesterase 3A (PDE3A) inhibitor, which raises cAMP levels. Elevated cAMP can activate PKA and subsequently enhance the phosphorylation of proteins that are part of Gm129's signaling network, thereby enhancing the functional activity of Gm129. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Terbutaline is a β2-adrenergic agonist that can increase intracellular cAMP by activating adenylate cyclase. The increased cAMP levels enhance PKA activity, which then can lead to the phosphorylation of proteins within the signaling pathways where Gm129 functions, indirectly enhancing the activity of Gm129. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Vardenafil is another PDE5 inhibitor, similar to Sildenafil | ||||||